By Ann Fordham and Martin Jelsma for Open Democracy. In April 2016, the UN will dedicate, for the third time in its history, a United Nations General Assembly Special Session (UNGASS) to discuss global drug policy. The UNGASS has the potential to be a ground-breaking moment that could change the course of the international drug control system. However, political divisions and entrenched institutional dynamics have dampened hopes that it will go down in history as the beginning of the end of the war on drugs.
At the joint request of Mexico, Colombia and Guatemala, the General Assembly decided to bring forward the convention of a special session to assess “the achievements and challenges in countering the world drug problem”, originally foreseen for 2019 or 2020. The three countries stated at the time that “revising the approach on drugs maintained so far by the international community can no longer be postponed”, and the UN needed to exercise leadership to “conduct an in-depth review analyzing all available options, including regulatory or market measures, in order to establish a new paradigm that would impede the flow of resources to organized crime groups”. An international meeting had to be convened, “capable of taking the decisions necessary to increase the effectiveness of the strategies and instruments with which the global community addresses the challenges of drugs and their consequences”.